Amgen (and Genetech) Does it Again!


At the end of 2012 the congress passed a bill to avoid the financial Fiscal Cliff. Unbeknownst to almost everyone Amgen lobbyists inserted a $500,000,000 payout to themselves as a rider to this bill. The bill passed without anyone knowing what they were  voting on.
Now they are trying a similar tactic. The NYT reports that these two companies are lobbying state legislatures to limit competition to their biological drugs that will lose patent protection in the next several years. The ability to have pharmacists substitute cheaper biosimilars in filling prescriptions would save our health care system billions of dollars. Europe has been allowing this for at least two years with no evidence of adverse consequences.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: